Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTE-051 in active rheumatoid arthritis
NCT02919475Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Sep 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of JTE-051 in rheumatoid arthritis (RA), sponsored by Akros Pharma Inc.. Started Sep 2016; status: completed.
02
Drugs
JTE-051
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02919475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02919475.